Dabing Chen

419 citations
4 papers · 238 indexed · h-index 2

Impact in

    • Advancements in Transdermal Drug Delivery
    • Advanced Drug Delivery Systems
    • Drug Solubulity and Delivery Systems
  • Biomaterials top 10%
    • Nanoparticle-Based Drug Delivery

Papers in

Dabing Chen

3 papers receiving 223 citations

Peers

Dabing Chen
Comparison fields: 5 of 55
  • Pharmaceutical Science 145
  • Biomaterials 93
  • Molecular Biology 132
  • Food Science 29
  • Dermatology 10
Replace Mahmoud A. Mahdy with:
Mahmoud A. Mahdy Egypt
Maria Cristina Cocenza Urban Brazil
Anam Khan Pakistan
T. R. Saini India
Arjunan Karuppaiah India
Raju Saka India
Areej M. Jaber Jordan
Ludmilla David de Moura Brazil
Nattisa Niyomtham Thailand
Dabing Chen relative to Mahmoud A. Mahdy Egypt Mahmoud A. Mahdy's profile →
Citations per field
00.5×
Mahmoud A. Mahdy · 1×
Citations per year

Countries citing papers authored by Dabing Chen

Since Specialization
Citations

This map shows the geographic impact of Dabing Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dabing Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dabing Chen more than expected).

Fields of papers citing papers by Dabing Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dabing Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dabing Chen. The network helps show where Dabing Chen may publish in the future.

Co-authors

The 18 scholars most cited alongside Dabing Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Dabing Chen Line = papers co-authored together Dabing Chen links everyone, so they are left out of the graph.

All Works

4 of 4 papers shown
#Work
1 20250
2 20201
3
[In vitro and in vivo study of two kinds of long-circulating solid lipid nanoparticles containing paclitaxel].
200251
4 2001186

About Dabing Chen

Dabing Chen is a scholar working on Molecular Medicine, Pharmaceutical Science, Hepatology, Hematology and Insect Science, having authored 4 papers that have together received 238 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (1 paper), Hepatitis B Virus Studies (1 paper), Antibiotic Resistance in Bacteria (1 paper), Hepatitis C virus research (1 paper), Hematopoietic Stem Cell Transplantation (1 paper), Advancements in Transdermal Drug Delivery (1 paper), Essential Oils and Antimicrobial Activity (1 paper) and Bee Products Chemical Analysis (1 paper). The work is most often cited by research in Pharmaceutical Science (145 citations), Biomaterials (93 citations), Molecular Biology (132 citations), Food Science (29 citations) and Dermatology (10 citations). Dabing Chen has collaborated with scholars based in China. Frequent co-authors include Wan-Liang Lü, Qiang Zhang, Qiang Zhang, Yu Zhang, Tingting Xiao, Jiaqi Sun, Xiaofeng Luo, Haojie Zhu, Zhi‐Hong Zheng and Ting Yang. Their work appears in journals such as Frontiers in Microbiology, Chemical and Pharmaceutical Bulletin, Blood and PubMed.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026